Equities

Kobayashi Pharmaceutical Co Ltd

Kobayashi Pharmaceutical Co Ltd

Actions
  • Price (EUR)31.20
  • Today's Change0.600 / 1.96%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 09 2024 18:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

  • Revenue in JPY (TTM)173.46bn
  • Net income in JPY20.34bn
  • Incorporated1919
  • Employees3.53k
  • Location
    Kobayashi Pharmaceutical Co LtdKDX Kobayashi Doshomachi Bldg.4-4-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
  • Phone+81 662311144
  • Websitehttps://www.kobayashi.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4967:TYO since
announced
Transaction
value
Focus Consumer Healthcare LLCDeal completed05 Oct 202305 Oct 2023Deal completed-20.41%75.00m
Data delayed at least 20 minutes, as of May 09 2024 07:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.